共 50 条
- [42] DETERMINATION OF MINOR IMPURITIES AND DIASTEREOMERS OF 6-[3-[(2-AMINO-1-OXOPENTYL)AMINO]-PYRROLIDINYL]-5-FLUORO-3-OXO-3H-PYRIDO[3,2,1-KL]PHENOXAZINE-2-CARBOXYLIC ACID HYDROCHLORIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (09): : 2005 - 2016
- [43] Structure determination of two structural analogs, named 3-[1-(2-fluoro-4-biphenyl)ethyl]-6-(4-fluorophenyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (C23H16F2N4S) and 3-[1-(2-fluoro-4-biphenyl)ethyl]-6-(4-chlorophenyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (C23H16ClFN4S) by synchrotron X-ray powder diffraction POWDER DIFFRACTION, 2017, 32 (04) : 279 - 289
- [44] High-performance liquid chromatographic determination of erdosteine and its optical active metabolite utilizing a fluorescent chiral tagging reagent, R-(-)-4-(N,N-dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 719 (1-2): : 177 - 189
- [45] High-performance liquid chromatographic determination of erdosteine and its optical active metabolite utilizing a fluorescent chiral tagging reagent, R-(-)-4-(N,N-dimethylaminosulfonyl)-7- (3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole Journal of Chromatography B, 1998, 719 (1-2): : 177 - 189
- [46] Crystal structure of N,N-diethyl-2-(2-(6-(4-methoxybenzyl)-7-oxo-7H-thiazolo[3,3-b][1,2,4] triazin-3-yl)phenoxy)acetamide, C25H26N4O4S ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (02): : 499 - 501
- [47] (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazo1-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950):: A rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor with reduced myotoxicity potential JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) : 2722 - 2733
- [49] The crystal structure of 3,4-dihydroxybenzoic acid-3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol - water (1/1/1), C30H36F2N6O9S ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (02): : 331 - 333
- [50] Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno [5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5 ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (02): : 313 - 315